Understanding the immunological landscape of England during SARS-CoV2 Omicron variant wave
View ORCID ProfileJoseph Shingleton, View ORCID ProfileSteven Dyke, Archie Herrick, Thomas Finnie
doi: https://doi.org/10.1101/2022.02.21.22271270
Joseph Shingleton
1UK Health Security Agency, PHAGE Joint Modelling Team
Steven Dyke
1UK Health Security Agency, PHAGE Joint Modelling Team
Archie Herrick
1UK Health Security Agency, PHAGE Joint Modelling Team
Thomas Finnie
1UK Health Security Agency, PHAGE Joint Modelling Team

Article usage
Posted February 22, 2022.
Understanding the immunological landscape of England during SARS-CoV2 Omicron variant wave
Joseph Shingleton, Steven Dyke, Archie Herrick, Thomas Finnie
medRxiv 2022.02.21.22271270; doi: https://doi.org/10.1101/2022.02.21.22271270
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)